Matches in Wikidata for { <http://www.wikidata.org/entity/Q38102355> ?p ?o ?g. }
Showing items 1 to 82 of
82
with 100 items per page.
- Q38102355 description "article científic" @default.
- Q38102355 description "article scientifique" @default.
- Q38102355 description "articol științific" @default.
- Q38102355 description "articolo scientifico" @default.
- Q38102355 description "artigo científico" @default.
- Q38102355 description "artigo científico" @default.
- Q38102355 description "artigo científico" @default.
- Q38102355 description "artikel ilmiah" @default.
- Q38102355 description "artikull shkencor" @default.
- Q38102355 description "artículo científico" @default.
- Q38102355 description "artículu científicu espublizáu en 2013" @default.
- Q38102355 description "bilimsel makale" @default.
- Q38102355 description "scienca artikolo" @default.
- Q38102355 description "scientific article published on 13 February 2013" @default.
- Q38102355 description "scientific article published on 13 February 2013" @default.
- Q38102355 description "scientific article published on 13 February 2013" @default.
- Q38102355 description "vedecký článok" @default.
- Q38102355 description "vetenskaplig artikel" @default.
- Q38102355 description "videnskabelig artikel" @default.
- Q38102355 description "vitenskapelig artikkel" @default.
- Q38102355 description "vitskapeleg artikkel" @default.
- Q38102355 description "vědecký článek" @default.
- Q38102355 description "wetenschappelijk artikel" @default.
- Q38102355 description "wissenschaftlicher Artikel" @default.
- Q38102355 description "наукова стаття, опублікована в лютому 2013" @default.
- Q38102355 description "научная статья" @default.
- Q38102355 description "научни чланак" @default.
- Q38102355 description "מאמר מדעי" @default.
- Q38102355 description "مقالة علمية نشرت في 13 فبراير 2013" @default.
- Q38102355 description "বৈজ্ঞানিক নিবন্ধ" @default.
- Q38102355 name "Incorporation of bleeding as an element of the composite end point in clinical trials of antithrombotic therapies in patients with non-ST-segment elevation acute coronary syndrome: validity, pitfalls, and future approaches" @default.
- Q38102355 name "Incorporation of bleeding as an element of the composite end point in clinical trials of antithrombotic therapies in patients with non-ST-segment elevation acute coronary syndrome: validity, pitfalls, and future approaches" @default.
- Q38102355 name "Incorporation of bleeding as an element of the composite end point in clinical trials of antithrombotic therapies in patients with non-ST-segment elevation acute coronary syndrome: validity, pitfalls, and future approaches" @default.
- Q38102355 type Item @default.
- Q38102355 label "Incorporation of bleeding as an element of the composite end point in clinical trials of antithrombotic therapies in patients with non-ST-segment elevation acute coronary syndrome: validity, pitfalls, and future approaches" @default.
- Q38102355 label "Incorporation of bleeding as an element of the composite end point in clinical trials of antithrombotic therapies in patients with non-ST-segment elevation acute coronary syndrome: validity, pitfalls, and future approaches" @default.
- Q38102355 label "Incorporation of bleeding as an element of the composite end point in clinical trials of antithrombotic therapies in patients with non-ST-segment elevation acute coronary syndrome: validity, pitfalls, and future approaches" @default.
- Q38102355 prefLabel "Incorporation of bleeding as an element of the composite end point in clinical trials of antithrombotic therapies in patients with non-ST-segment elevation acute coronary syndrome: validity, pitfalls, and future approaches" @default.
- Q38102355 prefLabel "Incorporation of bleeding as an element of the composite end point in clinical trials of antithrombotic therapies in patients with non-ST-segment elevation acute coronary syndrome: validity, pitfalls, and future approaches" @default.
- Q38102355 prefLabel "Incorporation of bleeding as an element of the composite end point in clinical trials of antithrombotic therapies in patients with non-ST-segment elevation acute coronary syndrome: validity, pitfalls, and future approaches" @default.
- Q38102355 P1433 Q38102355-3E307228-60B7-434C-BACB-85AD0324DC73 @default.
- Q38102355 P1476 Q38102355-4814D120-434A-4BB6-99A3-2C6AB54CCD88 @default.
- Q38102355 P2093 Q38102355-90700C3A-24AB-4A0D-9456-81005158D0AD @default.
- Q38102355 P304 Q38102355-9712D29C-84EC-4C02-B72A-673060C685D8 @default.
- Q38102355 P31 Q38102355-68FF246E-67F5-4DFD-8283-E396DC1D7CB2 @default.
- Q38102355 P356 Q38102355-1B6ED72B-ADC0-424D-A715-723B68EEEDAE @default.
- Q38102355 P407 Q38102355-3730F384-B52C-40D8-A723-3F145409E9D8 @default.
- Q38102355 P433 Q38102355-F1BD4988-839D-4232-A88D-7DEAE7281210 @default.
- Q38102355 P478 Q38102355-BCD59F2C-C4C8-4DCB-99F3-BFA3B5EE6C39 @default.
- Q38102355 P50 Q38102355-4501BCD3-D884-42AD-9EC0-CC3BC2DA6625 @default.
- Q38102355 P50 Q38102355-6E853385-1A6E-4F62-903B-25AEDDFD5C56 @default.
- Q38102355 P50 Q38102355-745EB9AF-481E-4D8E-A72A-F8B603EE77B0 @default.
- Q38102355 P50 Q38102355-770A21FD-A34A-48B9-9FC5-0715331B5306 @default.
- Q38102355 P50 Q38102355-7FBD4D1C-E634-4A4F-8B1C-B9CE27EAB89B @default.
- Q38102355 P50 Q38102355-8ACBC4D7-3595-4CAB-B65A-656F08AD4432 @default.
- Q38102355 P50 Q38102355-DAB03787-4CA0-4199-8C06-D959B14B9181 @default.
- Q38102355 P50 Q38102355-EE15218F-629B-4BA6-99E5-A7F953267404 @default.
- Q38102355 P577 Q38102355-3CA5CE77-625A-4BFA-B1CA-019A69F71F67 @default.
- Q38102355 P698 Q38102355-F6413E6A-3841-476C-8E5F-D171E7E0C42C @default.
- Q38102355 P921 Q38102355-CFDFBE45-9C64-45FC-A1B1-BA2E31C23F1C @default.
- Q38102355 P356 J.AHJ.2012.11.012 @default.
- Q38102355 P698 23622901 @default.
- Q38102355 P1433 Q2227156 @default.
- Q38102355 P1476 "Incorporation of bleeding as an element of the composite end point in clinical trials of antithrombotic therapies in patients with non-ST-segment elevation acute coronary syndrome: validity, pitfalls, and future approaches" @default.
- Q38102355 P2093 "Sunil V Rao" @default.
- Q38102355 P304 "644-54, 654.e1" @default.
- Q38102355 P31 Q13442814 @default.
- Q38102355 P356 "10.1016/J.AHJ.2012.11.012" @default.
- Q38102355 P407 Q1860 @default.
- Q38102355 P433 "5" @default.
- Q38102355 P478 "165" @default.
- Q38102355 P50 Q110877755 @default.
- Q38102355 P50 Q114430910 @default.
- Q38102355 P50 Q60697402 @default.
- Q38102355 P50 Q62633740 @default.
- Q38102355 P50 Q63101608 @default.
- Q38102355 P50 Q63101609 @default.
- Q38102355 P50 Q64684757 @default.
- Q38102355 P50 Q86192699 @default.
- Q38102355 P577 "2013-02-13T00:00:00Z" @default.
- Q38102355 P698 "23622901" @default.
- Q38102355 P921 Q266018 @default.